Work

New evidence on the clinical, genetic, and biochemical bases of GBA1-Parkinson's disease: prospects for treatment

Year: 2026

Type: review

Source: The Lancet Neurology

DOI: 10.1016/s1474-4422(26)00090-6

Authors: Elisa Menozzi, Marco Toffoli, Michela Deleidi, Donato A Di Monte, Fabio Blandini, Dimitri Krainc, Ellen Sidransky, Anthony H V Schapira

Institutions: Aligning Science Across Parkinson's, UCL Queen Square Institute of Neurology, University College London, Inserm, Institut des Maladies Génétiques Imagine, German Center for Neurodegenerative Diseases, University of Pavia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Northwestern University, National Institutes of Health, National Human Genome Research Institute

Language: English

Topic: Lysosomal Storage Disorders Research

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Green Box Arts, U.S. Department of Health and Human Services, Michael J. Fox Foundation for Parkinson's Research, EU Joint Programme – Neurodegenerative Disease Research, Aligning Science Across Parkinson’s, National Institutes of Health, Medical Research Council

Awards: G1978007690, JPND GBA - personalised medicine for Parkinson disease: clinical and therapeutic stratification, G7394720103

OpenAlex ID: W7161144540

FWCI: 17.1

Cites: 92

Cited by: 13

Related to: 10